Candidate Chemical definition

Candidate Chemical means a chemical that is a candidate for designation as a
Sample 1Sample 2Sample 3
Candidate Chemical means a chemical that is a candidate for designation as a Chemical of Concern, and that is identified as a Candidate Chemical under section 69502.2.
Sample 1Sample 2Sample 3

Examples of Candidate Chemical in a sentence

  • Although the plaintiff asked for a perfection of the contract for sale in his originating summons by registering the Transfer with SLA, I understood counsel for the plaintiff to be arguing that (i) the contract for sale of the Flat should be rectified to recognise that it was transacted on behalf of the first defendant as Ms De Silva’s lack of power to execute documents on behalf of the first defendant was a mere “technicality” and (ii) the Transfer should thus be registered.

  • DEO’s decision on the petition shall be final, subject to Contractor’s right to review pursuant to chapter 120, F.S. Exhaustion of administrative remedies is an absolute condition precedent to Contractor’s ability to pursue any other form of dispute resolution; provided however, that the Parties may employ the alternative dispute resolution procedures outlined in chapter 120, F.S.

  • DTSC is required to show that there is “potential exposure to the Candidate Chemical in the product” and that there is “potential for one or more exposures to contribute to or cause significant or widespread adverse public health and/or environmental impacts.” This process includes a pre-regulatory workshop, notice and comment, and a public hearing.

  • As a result, each Candidate Chemical identified as the basis for listing each of the initial Priority Products appears in one or more authoritative lists based on hazard traits [section 69502.2(a)(1)] and in one or more authoritative lists based on potential exposure concerns [section 69502.2(a)(2)].

  • Candidate Chemical – The SCP regulations identify a set of authoritative lists.2 Any chemical on one or more of these authoritative lists is a Candidate Chemical.

  • A report by the U.S. Department of Agriculture concluded that canned and packaged prepared food represents the largest food expenditure for the lowest-income households.19 DTSC is also concerned about potential adverse impacts to children from Candidate Chemical exposure from food packaging.

  • Admittance to the Hall of Champions is included in the technical program registration fee or the onsite exhibits- only registration fee.

  • The Candidate Chemical Engineer needs to consider many aspects and follow certain steps in the investigation process to interrogate the given scope of work.

  • Ray’s Family 966 Family/Professional Relations and Supports 966 Challenges in Communication and Transition 977 Reciprocity.

  • Consider, for example, a Candidate Chemical Engineer working for a water treatment company.

Related to Candidate Chemical

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Candidate means the person Introduced by the Agency to the Client for an Engagement including any officer, employee or other representative of the Candidate if the Candidate is a corporate body, and members of the Agency’s own staff;

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Candidate Committee means a committee established by a candidate pursuant to N.J.S.A. 19:44A-9(a), for the purpose of receiving contributions and making expenditures.

  • Opioid antidote means any drug, regardless of dosage amount or method of administration, which has been approved by the United States Food and Drug Administration (FDA) for the treatment of an opioid overdose. “Opioid antidote” includes, but is not limited to, naloxone hydrochloride, in any dosage amount, which is administered through nasal spray or any other FDA-approved means or methods.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Chemical agent shall mean any compound which, when suitably disseminated, produces incapacitating, damaging or lethal effects on people, animals, plants or material property.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Opioid antagonist means a drug that binds to opioid

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Compounds means a small molecule HMT inhibitor.

  • alternate aerodrome means an aerodrome to which an aircraft may proceed when it becomes either impossible or inadvisable to proceed to or to land at the aerodrome of intended landing where the necessary services and facilities are available, where aircraft performance requirements can be met and which is operational at the expected time of use;

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Acute toxicity means concurrent and delayed adverse effects that result from an acute exposure and occur within any short observation period, which begins when the exposure begins, may extend beyond the exposure period, and usually does not constitute a substantial portion of the life span of the organism.

  • POC (Proof of Concept) means testing the Software for evaluation purposes.